BE478232A - - Google Patents
Info
- Publication number
- BE478232A BE478232A BE478232DA BE478232A BE 478232 A BE478232 A BE 478232A BE 478232D A BE478232D A BE 478232DA BE 478232 A BE478232 A BE 478232A
- Authority
- BE
- Belgium
- Prior art keywords
- insulating layer
- emi
- substances
- mixture
- mixtures
- Prior art date
Links
- 239000000126 substance Substances 0.000 claims description 68
- 239000010410 layer Substances 0.000 claims description 60
- 239000000203 mixture Substances 0.000 claims description 45
- 229940088594 vitamin Drugs 0.000 claims description 29
- 235000013343 vitamin Nutrition 0.000 claims description 29
- 239000011782 vitamin Substances 0.000 claims description 29
- 229930003231 vitamin Natural products 0.000 claims description 29
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 26
- 239000000829 suppository Substances 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 241001465754 Metazoa Species 0.000 claims description 15
- 159000000007 calcium salts Chemical class 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 14
- 235000019155 vitamin A Nutrition 0.000 claims description 11
- 239000011719 vitamin A Substances 0.000 claims description 11
- 235000019166 vitamin D Nutrition 0.000 claims description 10
- 239000011710 vitamin D Substances 0.000 claims description 10
- 229960004494 calcium gluconate Drugs 0.000 claims description 9
- 235000013927 calcium gluconate Nutrition 0.000 claims description 9
- 239000004227 calcium gluconate Substances 0.000 claims description 9
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 230000009471 action Effects 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 229940110456 cocoa butter Drugs 0.000 claims description 7
- 235000019868 cocoa butter Nutrition 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 229940043430 calcium compound Drugs 0.000 claims description 6
- 150000001674 calcium compounds Chemical class 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- -1 ovules Substances 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 229960005069 calcium Drugs 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- 230000001754 anti-pyretic effect Effects 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 3
- 239000004859 Copal Substances 0.000 claims description 3
- 241000782205 Guibourtia conjugata Species 0.000 claims description 3
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 3
- 239000002221 antipyretic Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 229920001864 tannin Polymers 0.000 claims description 3
- 235000018553 tannin Nutrition 0.000 claims description 3
- 239000001648 tannin Substances 0.000 claims description 3
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 239000011241 protective layer Substances 0.000 claims description 2
- 229940035676 analgesics Drugs 0.000 claims 2
- 239000000730 antalgic agent Substances 0.000 claims 2
- 229940125716 antipyretic agent Drugs 0.000 claims 2
- 239000008298 dragée Substances 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 1
- 150000002506 iron compounds Chemical class 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 235000015961 tonic Nutrition 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 229960000716 tonics Drugs 0.000 claims 1
- 244000299461 Theobroma cacao Species 0.000 description 13
- 235000009470 Theobroma cacao Nutrition 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 238000000465 moulding Methods 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 239000005569 Iron sulphate Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical class [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000005749 Copper compound Substances 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229910000398 iron phosphate Inorganic materials 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH858128X | 1947-07-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE478232A true BE478232A (is") |
Family
ID=4542870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE478232D BE478232A (is") | 1947-07-04 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE478232A (is") |
| CH (1) | CH267221A (is") |
| DE (1) | DE858128C (is") |
| FR (1) | FR1003214A (is") |
| NL (1) | NL68059C (is") |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE951292C (de) * | 1952-12-21 | 1956-10-25 | Bayer Ag | Verfahren zur Herstellung pharmazeutischer Zubereitungen |
| DE1024930B (de) * | 1956-01-05 | 1958-02-27 | Mueller Otto | Verfahren zur Herstellung von reaktiven Feststoffgemischen |
| US2855152A (en) * | 1956-06-28 | 1958-10-07 | Robertshaw Fulton Controls Co | Thermostatically controlled fluid valve |
| EP0013131A3 (en) * | 1978-12-27 | 1981-01-07 | Mundipharma A.G. | Pharmaceutical composition in solid dosage form, and process for its production |
| DE3600084A1 (de) * | 1986-01-03 | 1987-07-09 | Scherer Gmbh R P | Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers |
| US4752479A (en) * | 1986-05-27 | 1988-06-21 | Ciba-Geigy Corporaton | Multi vitamin and mineral dietary supplement with controlled release bioavailable iron |
-
0
- BE BE478232D patent/BE478232A/fr unknown
- NL NL68059D patent/NL68059C/xx active
-
1946
- 1946-12-17 FR FR1003214D patent/FR1003214A/fr not_active Expired
-
1947
- 1947-07-04 CH CH267221D patent/CH267221A/de unknown
-
1949
- 1949-01-20 DE DEP31985A patent/DE858128C/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE858128C (de) | 1952-12-04 |
| NL68059C (is") | |
| CH267221A (de) | 1950-03-15 |
| FR1003214A (fr) | 1952-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5045340A (en) | Hard confectionery products containing mainly xylitol and a process of preparing same | |
| PL172354B1 (pl) | Nosnik substancji aktywnych , szczególnie farmaceutycznych PL PL PL PL | |
| DE69530215T2 (de) | Speiseeis | |
| FR2740300A1 (fr) | Revetement sans sucre obtenu par drageification dure et son procede d'obtention | |
| FR2593065A1 (fr) | Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation. | |
| US4692339A (en) | Process for addition and stabilization of vitamin C in a hard candy-like comestible | |
| JPH07502763A (ja) | 医薬活性物質の糖菓様送達システム | |
| CZ290816B6 (cs) | Způsob přípravy pastilek s obsahem flurbiprofenu | |
| BE478232A (is") | ||
| AU2003241138B2 (en) | Popping oral administration form | |
| US5063080A (en) | Sugar-free crust chocolates | |
| CA2119764C (fr) | Composition lipophile hydratee et procede pour son obtention | |
| JP2001114668A (ja) | チョコレート剤 | |
| SU1718773A1 (ru) | "Способ производства шоколадных конфет типа "Ассорти" | |
| CN111280285A (zh) | 一种夹心巧克力棒棒糖及其制备方法 | |
| GB2283899A (en) | Coated gelatin capsules | |
| RU2104651C1 (ru) | Способ производства помадных конфет | |
| EP0741564B1 (fr) | Nouveau procede de fabrication de suppositoires | |
| US1426006A (en) | Method of making pudding compositions | |
| JP2000342184A (ja) | ハードキャンディー菓子 | |
| US479580A (en) | Soluble chocolate | |
| CA2178220C (fr) | Nouveau procede de fabrication de suppositoires | |
| JPH0356708B2 (is") | ||
| FI83923B (fi) | Foerfarande foer framstaellning av huvudsakligen xylitol och maltitol innehaollande haorda karameller. | |
| FR2477875A1 (fr) | Nouveaux produits a base de vincamine |